Cargando…

Evolving BioAssay Ontology (BAO): modularization, integration and applications

The lack of established standards to describe and annotate biological assays and screening outcomes in the domain of drug and chemical probe discovery is a severe limitation to utilize public and proprietary drug screening data to their maximum potential. We have created the BioAssay Ontology (BAO)...

Descripción completa

Detalles Bibliográficos
Autores principales: Abeyruwan, Saminda, Vempati, Uma D, Küçük-McGinty, Hande, Visser, Ubbo, Koleti, Amar, Mir, Ahsan, Sakurai, Kunie, Chung, Caty, Bittker, Joshua A, Clemons, Paul A, Brudz, Steve, Siripala, Anosha, Morales, Arturo J, Romacker, Martin, Twomey, David, Bureeva, Svetlana, Lemmon, Vance, Schürer, Stephan C
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4108877/
https://www.ncbi.nlm.nih.gov/pubmed/25093074
http://dx.doi.org/10.1186/2041-1480-5-S1-S5
_version_ 1782327802493665280
author Abeyruwan, Saminda
Vempati, Uma D
Küçük-McGinty, Hande
Visser, Ubbo
Koleti, Amar
Mir, Ahsan
Sakurai, Kunie
Chung, Caty
Bittker, Joshua A
Clemons, Paul A
Brudz, Steve
Siripala, Anosha
Morales, Arturo J
Romacker, Martin
Twomey, David
Bureeva, Svetlana
Lemmon, Vance
Schürer, Stephan C
author_facet Abeyruwan, Saminda
Vempati, Uma D
Küçük-McGinty, Hande
Visser, Ubbo
Koleti, Amar
Mir, Ahsan
Sakurai, Kunie
Chung, Caty
Bittker, Joshua A
Clemons, Paul A
Brudz, Steve
Siripala, Anosha
Morales, Arturo J
Romacker, Martin
Twomey, David
Bureeva, Svetlana
Lemmon, Vance
Schürer, Stephan C
author_sort Abeyruwan, Saminda
collection PubMed
description The lack of established standards to describe and annotate biological assays and screening outcomes in the domain of drug and chemical probe discovery is a severe limitation to utilize public and proprietary drug screening data to their maximum potential. We have created the BioAssay Ontology (BAO) project (http://bioassayontology.org) to develop common reference metadata terms and definitions required for describing relevant information of low-and high-throughput drug and probe screening assays and results. The main objectives of BAO are to enable effective integration, aggregation, retrieval, and analyses of drug screening data. Since we first released BAO on the BioPortal in 2010 we have considerably expanded and enhanced BAO and we have applied the ontology in several internal and external collaborative projects, for example the BioAssay Research Database (BARD). We describe the evolution of BAO with a design that enables modeling complex assays including profile and panel assays such as those in the Library of Integrated Network-based Cellular Signatures (LINCS). One of the critical questions in evolving BAO is the following: how can we provide a way to efficiently reuse and share among various research projects specific parts of our ontologies without violating the integrity of the ontology and without creating redundancies. This paper provides a comprehensive answer to this question with a description of a methodology for ontology modularization using a layered architecture. Our modularization approach defines several distinct BAO components and separates internal from external modules and domain-level from structural components. This approach facilitates the generation/extraction of derived ontologies (or perspectives) that can suit particular use cases or software applications. We describe the evolution of BAO related to its formal structures, engineering approaches, and content to enable modeling of complex assays and integration with other ontologies and datasets.
format Online
Article
Text
id pubmed-4108877
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-41088772014-08-04 Evolving BioAssay Ontology (BAO): modularization, integration and applications Abeyruwan, Saminda Vempati, Uma D Küçük-McGinty, Hande Visser, Ubbo Koleti, Amar Mir, Ahsan Sakurai, Kunie Chung, Caty Bittker, Joshua A Clemons, Paul A Brudz, Steve Siripala, Anosha Morales, Arturo J Romacker, Martin Twomey, David Bureeva, Svetlana Lemmon, Vance Schürer, Stephan C J Biomed Semantics Proceedings The lack of established standards to describe and annotate biological assays and screening outcomes in the domain of drug and chemical probe discovery is a severe limitation to utilize public and proprietary drug screening data to their maximum potential. We have created the BioAssay Ontology (BAO) project (http://bioassayontology.org) to develop common reference metadata terms and definitions required for describing relevant information of low-and high-throughput drug and probe screening assays and results. The main objectives of BAO are to enable effective integration, aggregation, retrieval, and analyses of drug screening data. Since we first released BAO on the BioPortal in 2010 we have considerably expanded and enhanced BAO and we have applied the ontology in several internal and external collaborative projects, for example the BioAssay Research Database (BARD). We describe the evolution of BAO with a design that enables modeling complex assays including profile and panel assays such as those in the Library of Integrated Network-based Cellular Signatures (LINCS). One of the critical questions in evolving BAO is the following: how can we provide a way to efficiently reuse and share among various research projects specific parts of our ontologies without violating the integrity of the ontology and without creating redundancies. This paper provides a comprehensive answer to this question with a description of a methodology for ontology modularization using a layered architecture. Our modularization approach defines several distinct BAO components and separates internal from external modules and domain-level from structural components. This approach facilitates the generation/extraction of derived ontologies (or perspectives) that can suit particular use cases or software applications. We describe the evolution of BAO related to its formal structures, engineering approaches, and content to enable modeling of complex assays and integration with other ontologies and datasets. BioMed Central 2014-06-03 /pmc/articles/PMC4108877/ /pubmed/25093074 http://dx.doi.org/10.1186/2041-1480-5-S1-S5 Text en Copyright © 2014 Abeyruwan et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Proceedings
Abeyruwan, Saminda
Vempati, Uma D
Küçük-McGinty, Hande
Visser, Ubbo
Koleti, Amar
Mir, Ahsan
Sakurai, Kunie
Chung, Caty
Bittker, Joshua A
Clemons, Paul A
Brudz, Steve
Siripala, Anosha
Morales, Arturo J
Romacker, Martin
Twomey, David
Bureeva, Svetlana
Lemmon, Vance
Schürer, Stephan C
Evolving BioAssay Ontology (BAO): modularization, integration and applications
title Evolving BioAssay Ontology (BAO): modularization, integration and applications
title_full Evolving BioAssay Ontology (BAO): modularization, integration and applications
title_fullStr Evolving BioAssay Ontology (BAO): modularization, integration and applications
title_full_unstemmed Evolving BioAssay Ontology (BAO): modularization, integration and applications
title_short Evolving BioAssay Ontology (BAO): modularization, integration and applications
title_sort evolving bioassay ontology (bao): modularization, integration and applications
topic Proceedings
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4108877/
https://www.ncbi.nlm.nih.gov/pubmed/25093074
http://dx.doi.org/10.1186/2041-1480-5-S1-S5
work_keys_str_mv AT abeyruwansaminda evolvingbioassayontologybaomodularizationintegrationandapplications
AT vempatiumad evolvingbioassayontologybaomodularizationintegrationandapplications
AT kucukmcgintyhande evolvingbioassayontologybaomodularizationintegrationandapplications
AT visserubbo evolvingbioassayontologybaomodularizationintegrationandapplications
AT koletiamar evolvingbioassayontologybaomodularizationintegrationandapplications
AT mirahsan evolvingbioassayontologybaomodularizationintegrationandapplications
AT sakuraikunie evolvingbioassayontologybaomodularizationintegrationandapplications
AT chungcaty evolvingbioassayontologybaomodularizationintegrationandapplications
AT bittkerjoshuaa evolvingbioassayontologybaomodularizationintegrationandapplications
AT clemonspaula evolvingbioassayontologybaomodularizationintegrationandapplications
AT brudzsteve evolvingbioassayontologybaomodularizationintegrationandapplications
AT siripalaanosha evolvingbioassayontologybaomodularizationintegrationandapplications
AT moralesarturoj evolvingbioassayontologybaomodularizationintegrationandapplications
AT romackermartin evolvingbioassayontologybaomodularizationintegrationandapplications
AT twomeydavid evolvingbioassayontologybaomodularizationintegrationandapplications
AT bureevasvetlana evolvingbioassayontologybaomodularizationintegrationandapplications
AT lemmonvance evolvingbioassayontologybaomodularizationintegrationandapplications
AT schurerstephanc evolvingbioassayontologybaomodularizationintegrationandapplications